Current Things

Current Thing: Roe v. Wade Officially Overturned

Supreme Court Strikes Down NY Concealed Carry Law

PLAN Creates New Carrier

NASA Commissions Team to Study UFOs

Current Thing: Elon Pisses on a Hornet’s Nest

US Allegedly Developing a Real-Life Iron Man Suit

Current Thing: Depp Wins Defamation Case

Joe Rogan Shares His Identity Exploitation Experience

Armed Guards at Schools: Being Discussed

Image from NPR

New Thing: Monkeypoxalypse Trends on Twitter

New Thing: Bill Gates Trending as a ‘Bio Terrorist’

New Thing: Hillary for Prison Trends on Twitter

Twitter Executive Exposed Mocking Elon’s Disability and Confirming Censorship Efforts

Mass Shooting at a Church in California

10 Dead in Mass Shooting at a Buffalo, NY Supermarket

Rand Paul Stifles 40 Billion Ukraine Aid Bill

The Documentary 2000 Mules Invades Internet

Trump Wanted to Launch Missiles into Mexico

Biden Admin to Set Up ‘Disinformation Governance Board’

Johnny Depp Finally Heard

PASADENA, CA – APRIL 17: Comedian Joe Rogan performs during his appearance at The Ice House Comedy Club on April 17, 2019 in Pasadena, California. (Photo by Michael S. Schwartz/Getty Images)

Elons Twitter Allegedly Targeted for App Store Removal

Elon has Bought Twitter

Chronicles

recent posts

US Supreme Court Strikes Down NY Gun Law Restricting Concealed Carry

The Supreme Court struck down a NY gun law on June 23rd, 2022 requiring citizens to demonstrate “proper cause” to carry concealed firearms outside their homes. The court voted 6-3, arguing that the 108-year-old state law violated the Constitution’s 14th Amendment by preventing “law-abiding citizens with ordinary self-defense needs from exercising their right to keep […]

PLAN Creates ‘Fujian’ Carrier, Similar to Western Carriers

The Fujian is equipped with state of the art weaponry and aircraft-launch technology and caps years of expansion by PLAN as it seeks to become a global force. It’s unclear how Taiwan currently perceives this development; however, it’s reasonable to speculate that this development may be anxiety provoking for Taiwan at some level.

Cancer study Leaves Patients Cancer Free

A paper published on Sunday at The New England Journal of Medicine outlined a study of 18 rectal cancer patients who were given dostarlimab every three weeks for six months and ended up cancer-free, including the first patient who is now two years out from the trial.